Montemac A Tablet is a fixed-dose combination medication comprising Acebrophylline, a bronchodilator, and Montelukast, a leukotriene receptor antagonist. It is indicated for the relief of symptoms associated with chronic obstructive pulmonary disease (COPD) and asthma, including cough, wheezing, and shortness of breath. The tablet works by relaxing the airway muscles, increasing bronchodilation, and inhibiting the effects of leukotrienes, which are potent inflammatory mediators. The combination of these two agents provides a synergistic effect, allowing for improved lung function and reduced severity of symptoms. Montemac A Tablet is available in a convenient once-daily dosage form, making it an attractive option for patients requiring long-term therapy. The medication is contraindicated in patients with known hypersensitivity to Acebrophylline or Montelukast, as well as those with severe renal or hepatic impairment. As with any medication, patients should be monitored for potential side effects, including headache, nausea, and diarrhea.